Literature DB >> 29274253

miR-200a enhances TRAIL-induced apoptosis in gastric cancer cells by targeting A20.

Tianshu Guo1,2, Ye Zhang1,2, Xiujuan Qu1,2, Xiaofang Che1,2, Ce Li1,2, Yibo Fan1,2, Xing Wan1,2, Rui Ma1,2, Kezuo Hou1,2, Huiming Zhou1,2, Xiaowei He1,2, Xuejun Hu3, Yunpeng Liu1,2, Ling Xu1,2.   

Abstract

Tumor necrosis factor-alpha-related apoptosis-inducing ligand (TRAIL) triggers apoptosis by inducing the death-inducing signaling complex (DISC) formation. Recently, TNFα-induced protein 3 (TNFAIP3, A20) was reported to prevent TRAIL-induced caspase 8 cleavage in the DISC by mediating ubiquitination of RIP1 in glioblastoma. However, whether A20 regulates caspase 8 cleavage in the DISC when TRAIL induces apoptosis in gastric cancer cells is unknown. In the present study, A20 interacted with RIP1 and DR4 in MGC803 and SGC7901 gastric cancer cells. Treatment with TRAIL promoted the A20-mediated polyubiquitination of RIP1, caspase 8 translocation into the DISC, and the interaction between caspase 8 and ubiquitinated RIP1. Inhibition of A20 expression prevented the polyubiquitination of RIP1 and promoted caspase 8 cleavage. Moreover, our data clarified that A20 is a target of miR-200a. Overexpression of miR-200a inhibited A20 expression and polyubiquitination of RIP1 and then promoted cleavage of caspase 8 and TRAIL-triggered apoptosis. Taken together, our results indicate that miR-200a enhanced TRAIL-triggered apoptosis in gastric cancer cells by targeting A20.
© 2018 International Federation for Cell Biology.

Entities:  

Keywords:  A20; RIP1; TRAIL; caspase-8

Mesh:

Substances:

Year:  2018        PMID: 29274253     DOI: 10.1002/cbin.10924

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  10 in total

1.  MiR-200a with CDC7 as a direct target declines cell viability and promotes cell apoptosis in Wilm's tumor via Wnt/β-catenin signaling pathway.

Authors:  Xiu-Ling Liang; Yu-Long Wang; Pei-Rong Wang
Journal:  Mol Cell Biochem       Date:  2021-02-18       Impact factor: 3.396

2.  The Role of MiRNA in Cancer: Pathogenesis, Diagnosis, and Treatment.

Authors:  Erez Uzuner; Gizem Tugçe Ulu; Sevim Beyza Gürler; Yusuf Baran
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Advances in the Study of the Ubiquitin-Editing Enzyme A20.

Authors:  Wenya Bai; Siying Huo; Junjie Li; Jianlin Shao
Journal:  Front Pharmacol       Date:  2022-05-03       Impact factor: 5.988

4.  LncRNA PINK1-AS promotes Gαi1-driven gastric cancer tumorigenesis by sponging microRNA-200a.

Authors:  Yan Lv; Yin Wang; Yu Song; Shu-Sheng Wang; Kai-Wen Cheng; Zhi-Qing Zhang; Jin Yao; Li-Na Zhou; Zhuo-Yan Ling; Cong Cao
Journal:  Oncogene       Date:  2021-05-06       Impact factor: 9.867

5.  MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathway.

Authors:  Han Guan; Zonghao You; Can Wang; Fang Fang; Rui Peng; Likai Mao; Bin Xu; Ming Chen
Journal:  Cancer Med       Date:  2019-02-19       Impact factor: 4.452

6.  A20 targets PFKL and glycolysis to inhibit the progression of hepatocellular carcinoma.

Authors:  Yilu Feng; Ye Zhang; Yi Cai; Ruijie Liu; Miaolong Lu; Tangzhiming Li; Ying Fu; Ming Guo; Huichao Huang; Yifu Ou; Yongheng Chen
Journal:  Cell Death Dis       Date:  2020-02-03       Impact factor: 8.469

7.  A20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanoma.

Authors:  Weinan Guo; Jinyuan Ma; Sen Guo; Huina Wang; Sijia Wang; Qiong Shi; Lin Liu; Tao Zhao; Fengfan Yang; Shuyang Chen; Jianru Chen; Jianhong Zhao; Chen Yu; Xiuli Yi; Yuqi Yang; Jingjing Ma; Qingrong Ni; Guannan Zhu; Tianwen Gao; Chunying Li
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

Review 8.  The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer.

Authors:  Yanping Yue; Xinrong Lin; Xinyue Qiu; Lei Yang; Rui Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-13

Review 9.  The role of miR-200 family in the regulation of hallmarks of cancer.

Authors:  Klaudia Klicka; Tomasz M Grzywa; Aleksandra Mielniczuk; Alicja Klinke; Paweł K Włodarski
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

Review 10.  The role of deubiquitinating enzymes in gastric cancer.

Authors:  Jiangang Sun; Xiaojing Shi; M A A Mamun; Yongshun Gao
Journal:  Oncol Lett       Date:  2019-11-07       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.